Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Fully Closed-loop Insulin Delivery on Renal Oxygenation in People With Type 2 Diabetes and Chronic Kidney Disease: an Open-label, Single-center, Randomized Two-arm Parallel Trial

NCT06925217 is registered in ClinicalTrials.gov with Heba Al-Alwan as lead sponsor.

NCT NCT06925217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06925217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Fully Closed-loop Insulin Delivery on Renal Oxygenation in People With Type 2 Diabetes and Chronic Kidney Disease: an Open-label, Single-center, Randomized Two-arm Parallel Trial
Lead sponsor
Heba Al-Alwan
Phase
Not applicable
Overall status
Recruiting
Start date
June 16, 2025
Completion date
May 31, 2027
Enrollment
76 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease stage 3, type 2 diabetes